These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
426 related articles for article (PubMed ID: 15302896)
1. NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans. Kurian JR; Bajad SU; Miller JL; Chin NA; Trepanier LA J Pharmacol Exp Ther; 2004 Dec; 311(3):1171-8. PubMed ID: 15302896 [TBL] [Abstract][Full Text] [Related]
2. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes. Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605 [TBL] [Abstract][Full Text] [Related]
3. Unusual dehydroxylation of antimicrobial amidoxime prodrugs by cytochrome b5 and NADH cytochrome b5 reductase. Saulter JY; Kurian JR; Trepanier LA; Tidwell RR; Bridges AS; Boykin DW; Stephens CE; Anbazhagan M; Hall JE Drug Metab Dispos; 2005 Dec; 33(12):1886-93. PubMed ID: 16131524 [TBL] [Abstract][Full Text] [Related]
4. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes. Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495 [TBL] [Abstract][Full Text] [Related]
5. Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5. Kurian JR; Chin NA; Longlais BJ; Hayes KL; Trepanier LA Chem Res Toxicol; 2006 Oct; 19(10):1366-73. PubMed ID: 17040106 [TBL] [Abstract][Full Text] [Related]
6. Discovery and characterization of a cytochrome b5 variant in humans with impaired hydroxylamine reduction capacity. Kurian JR; Longlais BJ; Trepanier LA Pharmacogenet Genomics; 2007 Aug; 17(8):597-603. PubMed ID: 17622936 [TBL] [Abstract][Full Text] [Related]
7. Interaction of ferric complexes with NADH-cytochrome b5 reductase and cytochrome b5: lipid peroxidation, H2O2 generation, and ferric reduction. Yang MX; Cederbaum AI Arch Biochem Biophys; 1996 Jul; 331(1):69-78. PubMed ID: 8660685 [TBL] [Abstract][Full Text] [Related]
8. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748 [TBL] [Abstract][Full Text] [Related]
9. Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction. Sacco JC; Trepanier LA Pharmacogenet Genomics; 2010 Jan; 20(1):26-37. PubMed ID: 19997042 [TBL] [Abstract][Full Text] [Related]
10. In vitro effects of myricetin, morin, apigenin, (+)-taxifolin, (+)-catechin, (-)-epicatechin, naringenin and naringin on cytochrome b5 reduction by purified NADH-cytochrome b5 reductase. Çelik H; Koşar M; Arinç E Toxicology; 2013 Jun; 308():34-40. PubMed ID: 23567315 [TBL] [Abstract][Full Text] [Related]
11. Hepatic, extrahepatic, microsomal, and mitochondrial activation of the N-hydroxylated prodrugs benzamidoxime, guanoxabenz, and Ro 48-3656 ([[1-[(2s)-2-[[4-[(hydroxyamino)iminomethyl]benzoyl]amino]-1-oxopropyl]-4-piperidinyl]oxy]-acetic acid). Clement B; Mau S; Deters S; Havemeyer A Drug Metab Dispos; 2005 Nov; 33(11):1740-7. PubMed ID: 16118330 [TBL] [Abstract][Full Text] [Related]
12. Redox cycling of bleomycin-Fe(III) and DNA degradation by isolated NADH-cytochrome b5 reductase: involvement of cytochrome b5. Mahmutoglu I; Kappus H Mol Pharmacol; 1988 Oct; 34(4):578-83. PubMed ID: 2459594 [TBL] [Abstract][Full Text] [Related]
13. Fractionation of liver microsomes with polyethylene glycol and purification of NADH-cytochrome b5 oxidoreductase and cytochrome b5. Yang MX; Cederbaum AI Arch Biochem Biophys; 1994 Dec; 315(2):438-44. PubMed ID: 7986089 [TBL] [Abstract][Full Text] [Related]
14. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes. Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855 [TBL] [Abstract][Full Text] [Related]
15. The reducing ability of iron chelates by NADH-cytochrome B5 reductase or cytochrome B5 responsible for NADH-supported lipid peroxidation. Miura A; Tampo Y; Yonaha M Biochem Mol Biol Int; 1995 Sep; 37(1):141-50. PubMed ID: 8653076 [TBL] [Abstract][Full Text] [Related]
16. Microsomal NADH-cytochrome b5 reductase of bovine brain: purification and properties. Tamura M; Yubisui T; Takeshita M J Biochem; 1983 Nov; 94(5):1547-55. PubMed ID: 6654871 [TBL] [Abstract][Full Text] [Related]
17. The role of microsomal cytochrome b5 in the metabolism of ethanol, drugs and the desaturation of fatty acids. Ozols J Ann Clin Res; 1976; 8 Suppl 17():182-92. PubMed ID: 12714 [TBL] [Abstract][Full Text] [Related]
18. 1-Hydroxyethyl radical formation during NADPH- and NADH-dependent oxidation of ethanol by human liver microsomes. Rao DN; Yang MX; Lasker JM; Cederbaum AI Mol Pharmacol; 1996 May; 49(5):814-21. PubMed ID: 8622631 [TBL] [Abstract][Full Text] [Related]
19. Identification of cytochrome-b5 reductase as the enzyme responsible for NADH-dependent lucigenin chemiluminescence in human spermatozoa. Baker MA; Krutskikh A; Curry BJ; Hetherington L; Aitken RJ Biol Reprod; 2005 Aug; 73(2):334-42. PubMed ID: 15858218 [TBL] [Abstract][Full Text] [Related]
20. Effects of chronic exposure to cadmium on renal cytochrome P450-dependent monooxygenase system in rats. Plewka A; Plewka D; Nowaczyk G; Brzóska MM; Kamiński M; Moniuszko-Jakoniuk J Arch Toxicol; 2004 Apr; 78(4):194-200. PubMed ID: 14595535 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]